All stories

1 outlets · filed 7 November 2026

US regulator investigates tumour risk in children given Novartis gene therapy

This story is from the archive. It was covered between 7 November 2026 and 7 November 2026, and nothing below has been updated since. See what is happening now.

The US ⁠Food and Drug Administration said ⁠on Friday it was investigating a ⁠risk of neoplasia, or tumour formation including malignancy, associated with Novartis’ gene therapy Zolgensma. The Swiss drug maker earlier in the day disclosed two cases in which tumours in children showed evidence of bein

How it broke

South China Morning Post
1outlets
0videos
1articles

More on Health

Every Health story, across every outlet